Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Re: The impact of superselective adrenal artery embolization on renal function in patients with primary aldosteronism: a prospective cohort study

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Lai ZQ, Fu Y, Liu JW, Zhang HJ, Zhang H, Liang NP, et al. The impact of superselective adrenal artery embolization on renal function in patients with primary aldosteronism: a prospective cohort study. Hypertens Res. 2023. https://doi.org/10.1038/s41440-023-01503-8.

  2. Hokotate H, Inoue H, Baba Y, Tsuchimochi S, Nakajo M. Aldosteronomas: experience with superselective adrenal arterial embolization in 33 cases. Radiology. 2003;227:401–6.

    Article  PubMed  Google Scholar 

  3. Zhang H, Li Q, Liu X, Zhao Z, He H, Sun F, et al. Adrenal artery ablation for primary aldosteronism without apparent aldosteronoma: an efficacy and safety, proof‐of‐principle trial. J Clin Hypertens. 2020;22:1618–26.

    Article  Google Scholar 

  4. Dong H, Zou Y, He J, Deng Y, Chen Y, Song L, et al. Superselective adrenal arterial embolization for idiopathic hyperaldosteronism:12‐month results from a proof‐of‐principle trial. Catheter Cardiovasc Interv. 2021;97:976–81.

    Article  PubMed  Google Scholar 

  5. Zhao Z, Liu X, Zhang H, Li Q, He H, Yan Z, et al. Catheter-based adrenal ablation remits primary aldosteronism: a randomized medication-controlled trial. Circulation. 2021;144:580–2.

    Article  PubMed  Google Scholar 

  6. Rossi GP, Bisogni V, Bacca AV, Belfiore A, Cesari M, Concistré A, et al. The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism. Int J Cardiol Hypertens. 2020;5:100029.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Rossi GP. Primary aldosteronism: JACC state-of-the-art review. J Am Coll Cardiol. 2019;74:2799–2811.

    Article  CAS  PubMed  Google Scholar 

  8. Marzano L, Kazory A, Husain-Syed F, Ronco C. Prognostic models to predict complete resolution of hypertension after adrenalectomy in primary aldosteronism: a systematic review and meta-analysis. Clin Endocrinol. 2023;99:17–34.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giulio Cabrelle.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cabrelle, G., Zanon, C. & Rossi, G.P. Re: The impact of superselective adrenal artery embolization on renal function in patients with primary aldosteronism: a prospective cohort study. Hypertens Res (2024). https://doi.org/10.1038/s41440-024-01664-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41440-024-01664-0

Keywords

Search

Quick links